Published in Plasmid on March 01, 1981
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun (1986) 6.92
Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pestis. J Bacteriol (1981) 5.11
Secretion of Yop proteins by Yersiniae. Infect Immun (1990) 4.64
Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev (1991) 4.53
Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun (1985) 4.36
Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis. Infect Immun (1984) 4.07
Homology between virF, the transcriptional activator of the Yersinia virulence regulon, and AraC, the Escherichia coli arabinose operon regulator. J Bacteriol (1989) 3.89
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
Vwa+ phenotype of Yersinia enterocolitica. Infect Immun (1983) 3.72
LcrD, a membrane-bound regulator of the Yersinia pestis low-calcium response. J Bacteriol (1991) 3.43
Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis. J Bacteriol (1990) 3.09
Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev (2004) 3.03
Virulence plasmid-associated autoagglutination in Yersinia spp. J Bacteriol (1984) 3.01
Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination. Infect Immun (1985) 2.81
Isolation and characterization of Ca2+-blind mutants of Yersinia pestis. J Bacteriol (1985) 2.49
Nucleotide sequence of the plasminogen activator gene of Yersinia pestis: relationship to ompT of Escherichia coli and gene E of Salmonella typhimurium. Infect Immun (1989) 2.45
Detection and enumeration of virulent Yersinia enterocolitica in food by DNA colony hybridization. Appl Environ Microbiol (1983) 2.43
A low-Ca2+ response operon encodes the V antigen of Yersinia pestis. Infect Immun (1986) 2.39
The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes. J Bacteriol (1991) 2.30
Transfer of the virulence plasmid of Yersinia pestis to Yersinia pseudotuberculosis. Infect Immun (1985) 2.24
Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol (1998) 2.22
The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J Bacteriol (1998) 2.18
Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun (2002) 2.16
Plasminogen activator/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect Immun (1988) 2.15
Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species. J Clin Microbiol (1998) 2.13
lcrH, a gene necessary for virulence of Yersinia pestis and for the normal response of Y. pestis to ATP and calcium. Infect Immun (1989) 2.12
Genetic analysis of the yopE region of Yersinia spp.: identification of a novel conserved locus, yerA, regulating yopE expression. J Bacteriol (1990) 2.12
LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. J Bacteriol (1993) 2.08
New virulence-associated plasmid in Yersinia enterocolitica. J Clin Microbiol (1982) 2.03
Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect Immun (1988) 1.90
Multiple effects of lcrD mutations in Yersinia pestis. J Bacteriol (1993) 1.87
Resistance to pesticin, storage of iron, and invasion of HeLa cells by Yersiniae. Infect Immun (1987) 1.80
Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72
Current trends in plague research: from genomics to virulence. Clin Med Res (2006) 1.68
Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66
Mutations in yscC, yscD, and yscG prevent high-level expression and secretion of V antigen and Yops in Yersinia pestis. J Bacteriol (1995) 1.62
The gene coding for the 190,000-dalton iron-regulated protein of Yersinia species is present only in the highly pathogenic strains. Infect Immun (1989) 1.62
lcrR, a low-Ca2(+)-response locus with dual Ca2(+)-dependent functions in Yersinia pestis. J Bacteriol (1990) 1.41
Reevaluation of the virulence phenotype of the inv yadA double mutants of Yersinia pseudotuberculosis. Infect Immun (1997) 1.36
Relationship of virulence-associated autoagglutination to hemagglutinin production in Yersinia enterocolitica and Yersinia enterocolitica-like bacteria. Infect Immun (1983) 1.35
Evidence for two evolutionary lineages of highly pathogenic Yersinia species. J Bacteriol (1995) 1.32
Physiological basis of the low calcium response in Yersinia pestis. Infect Immun (1994) 1.31
YscB of Yersinia pestis functions as a specific chaperone for YopN. J Bacteriol (1998) 1.31
Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect Immun (2004) 1.26
Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun (2006) 1.17
YopK regulates the Yersinia pestis type III secretion system from within host cells. Mol Microbiol (2011) 1.11
Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli. Infect Immun (1999) 1.10
Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague. PLoS One (2009) 1.07
Structural and functional similarities between the replication region of the Yersinia virulence plasmid and the RepFIIA replicons. J Bacteriol (1990) 1.05
YscO of Yersinia pestis is a mobile core component of the Yop secretion system. J Bacteriol (1998) 1.02
The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS One (2009) 1.01
Targeting type III secretion in Yersinia pestis. Antimicrob Agents Chemother (2008) 1.00
Calcium-regulated type III secretion of Yop proteins by an Escherichia coli hha mutant carrying a Yersinia pestis pCD1 virulence plasmid. Infect Immun (2006) 0.97
Yersinia pestis Ail: multiple roles of a single protein. Front Cell Infect Microbiol (2012) 0.92
Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect Immun (2006) 0.91
Integration of the Vwa plasmid into the chromosome of Yersinia pestis strains harboring F' plasmids of Escherichia coli. Infect Immun (1985) 0.90
YopK controls both rate and fidelity of Yop translocation. Mol Microbiol (2012) 0.90
Expression of a functional secreted YopN-TyeA hybrid protein in Yersinia pestis is the result of a +1 translational frameshift event. J Bacteriol (2004) 0.90
Susceptibility of Campylobacter jejuni and Yersinia enterocolitica to UV radiation. Appl Environ Microbiol (1987) 0.89
The recent emergence of plague: a process of felonious evolution. Microb Ecol (2004) 0.88
Induction of the Yersinia type 3 secretion system as an all-or-none phenomenon. J Mol Biol (2007) 0.86
The SycN/YscB chaperone-binding domain of YopN is required for the calcium-dependent regulation of Yop secretion by Yersinia pestis. Front Cell Infect Microbiol (2013) 0.83
Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague. PLoS Pathog (2015) 0.82
In vitro expression of a 22-kilodalton Yersinia pestis polypeptide immunologically related to the 25-kilodalton plasmid-encoded protein of the three pathogenic Yersinia species. Infect Immun (1988) 0.82
Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague. MBio (2015) 0.80
Recent findings regarding maintenance of enzootic variants of Yersinia pestis in sylvatic reservoirs and their significance in the evolution of epidemic plague. Vector Borne Zoonotic Dis (2010) 0.80
Repression of the virulence of Yersinia pestis by an F' plasmid. Infect Immun (1983) 0.80
Plasmid DNA relatedness among different serogroups of Yersinia pseudotuberculosis. J Clin Microbiol (1985) 0.77
Isolation of Francisella tularensis and Yersinia pestis from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination. Front Microbiol (2017) 0.75
Yopp-expressing variant ofY. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia. PLoS One (2013) 0.75
YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection. PLoS One (2017) 0.75
Classic Spotlight: Studies on the Low-Calcium Response of Yersinia pestis Reveal the Secrets of Plague Pathogenesis. J Bacteriol (2016) 0.75
Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun (2001) 2.67
Plasmid R6K DNA replication. III. Regulatory properties of the pi initiation protein. J Mol Biol (1982) 2.12
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem (1993) 1.72
Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry (1999) 1.55
Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.53
Mode of action of pesticin. J Bacteriol (1969) 1.51
Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr D Biol Crystallogr (2000) 1.47
Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine (1993) 1.32
Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun (2002) 1.26
Structural properties of the beta origin of replication of plasmid R6K. J Biol Chem (1983) 1.22
Evidence for P-N bond scission in phosphoroamidate nerve agent adducts of human acetylcholinesterase. Biochemistry (2000) 1.21
N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Biochem J (1993) 1.20
Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J Biol Chem (1994) 1.14
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun (2003) 1.11
The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant. J Biol Chem (1991) 1.10
ColE1 DNA sequences interacting in cis, essential for mitomycin-C induced lethality. Mol Gen Genet (1979) 1.08
Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers. Biochemistry (1999) 1.05
Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge. J Virol (1989) 1.04
Engineering resistance to 'aging' of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center. FEBS Lett (1993) 1.04
Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase. J Biol Chem (1995) 1.03
Transduction of Pasteurella pestis. Virology (1972) 1.01
Chloramphenicol and puromycin as inducers of colicinogenic bacteria. Biochem Biophys Res Commun (1970) 1.01
Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels. Biochem J (1998) 1.00
The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors. J Biol Chem (1996) 1.00
Interrelations between assembly and secretion of recombinant human acetylcholinesterase. J Biol Chem (1993) 1.00
Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. Biochemistry (1995) 1.00
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines. Infect Immun (2003) 1.00
Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. Biochem J (1995) 0.99
The "back door" hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis. J Biol Chem (1994) 0.99
Evaluation of anchorage-dependent cell propagation systems for production of human acetylcholinesterase by recombinant 293 cells. Cytotechnology (1993) 0.95
Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts. Chem Res Toxicol (2001) 0.94
Cleavage maps of a tetracycline plasmid from Staphylococcus aureus. J Bacteriol (1978) 0.94
Identification and characterization of the functional alpha origin of DNA replication of the R6K plasmid and its relatedness to the R6K beta and gamma origins. Mol Gen Genet (1987) 0.94
Functional characteristics of the oxyanion hole in human acetylcholinesterase. J Biol Chem (1998) 0.93
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen. Infect Immun (2005) 0.93
Effect of human acetylcholinesterase subunit assembly on its circulatory residence. Biochem J (2001) 0.90
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors. Biochem J (1998) 0.89
Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochem J (2001) 0.89
A DNA segment within the colicin E1 structural gene on ColE1 affecting immunity to colicin. Mol Gen Genet (1978) 0.88
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Vaccine (2005) 0.87
Transcription signals in a region essential for replication of plasmid R6K. Plasmid (1985) 0.87
Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase? Biochemistry (2001) 0.87
Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase. Mol Pharmacol (1994) 0.86
A preliminary comparison of structural models for catalytic intermediates of acetylcholinesterase. Chem Biol Interact (1999) 0.86
Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects. J Biol Chem (1987) 0.86
Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives. Mol Pharmacol (1996) 0.86
Reversal of signal-mediated cellular retention by subunit assembly of human acetylcholinesterase. J Biol Chem (1994) 0.86
Partitioning of electrostatic and conformational contributions in the redox reactions of modified cytochromes c. Biochim Biophys Acta (1979) 0.86
Bovine acetylcholinesterase: cloning, expression and characterization. Biochem J (1998) 0.85
Variation in the CD4+ and CD8+ populations in lymph nodes does not reflect that in the blood during SIVMNE/E11S infection of macaques. J Med Primatol (1992) 0.85
The study of 1-electron equivalent oxidation-reduction reactions by fast pulse generation of reagents. Cytochrome c/ferri-ferrocyanide system. J Biol Chem (1976) 0.84
Overexpressed monomeric human acetylcholinesterase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos. J Neurochem (1994) 0.84
Alpha and beta replication origins of plasmid R6K show similar distortions of the DNA helix in vivo. Proc Natl Acad Sci U S A (1990) 0.84
Identification of the P1 compatibility and plasmid maintenance locus by a mini P1/ac+-plasmid. Virology (1979) 0.84
Structural modifications of the omega loop in human acetylcholinesterase. FEBS Lett (1996) 0.83
Novel adjuvant strategies for experimental malaria and AIDS vaccines. Ann N Y Acad Sci (1993) 0.82
Intramolecular electron transfer and binding constants in iron hexacyanide-cytochrome c complexes as studied by pulse radiolysis. Biochim Biophys Acta (1979) 0.82
Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus. Vaccine (1991) 0.82
Reduction of ferricytochrome c by hydrogen atoms: evidence for intramolecular transfer of reducing equivalent. Biochim Biophys Acta (1974) 0.82
Bovine interferon alpha genes. Structure and expression. J Biol Chem (1985) 0.81
Reaction of cytochrome c with one-electron redox reagents. I. Reduction of ferricytochrome c by the hydrated electron produced by pulse radiolysis. Biochim Biophys Acta (1973) 0.80
Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometry. FEBS Lett (1997) 0.80
Theoretical and experimental investigations of electrostatic effects on acetylcholinesterase catalysis and inhibition. Chem Biol Interact (1999) 0.80
Reaction of hydrated electrons with ferricytochrome C. Science (1973) 0.80
Aging of somanyl-acetylcholinesterase adducts: facts and models. Biochem J (1997) 0.79
Altered (copy-up) forms of initiator protein pi suppress the point mutations inactivating the gamma origin of plasmid R6K. J Bacteriol (1995) 0.79
Three novel plasmid R6K proteins act in concert to distort DNA within the alpha and beta origins of DNA replication. Mol Microbiol (1996) 0.79
On the induction of a recombination-deficient mutant of Escherichia coli K-12. Genet Res (1967) 0.79
Molecular aspects of genetic instability of an artificial 68 bp perfect palindrome in Escherichia coli. Mol Gen Genet (1987) 0.79
Effects of alcohol/water mixtures on the structure and reactivity of cytochrome c. Biochim Biophys Acta (1978) 0.79
The lethal effect and the inhibition of colicin production by leucine on a phenylalanine requiring E. coli strain as a function of age and dilution of culture. Zentralbl Bakteriol Orig A (1979) 0.79
Conformation-dependent participation of the protein in electron equivalent transfer to cytochrome c. Biochim Biophys Acta (1977) 0.78
Mutagenic and colicine-inducing activity of two antioxidants: pyrogallol and purpurogallin. Mutat Res (1979) 0.77
Study of biochemical redox processes by the technique of pulse radiolysis. Biochim Biophys Acta (1975) 0.77
Genetic and physical characterization of P1dlw prophage and its derivatives. Virology (1978) 0.76
New antibiotic substance produced by Salmonella typhimurium LT2. J Bacteriol (1982) 0.75
Production of monoclonal antibodies toward bovine interferons-alpha suitable for immunopurification. J Interferon Res (1989) 0.75
Mutations not altering the symmetrical sequences in the trp operator yield a constitutive phenotype. Mol Gen Genet (1984) 0.75
Isolation of bovine IFN-alpha genes and their expression in bacteria. Methods Enzymol (1986) 0.75
Genetic engineering of human interferons from lymphoblastoid cells: II. Construction of trp expression plasmids and their use for efficient expression of IFN-alpha J1. Adv Biotechnol Processes (1985) 0.75
Induction and characterization of bovine leukocyte interferon. Methods Enzymol (1986) 0.75
Tetracycline resistance expressed by pSC101 hybrids. Contrib Microbiol Immunol (1979) 0.75
Reduction of ferricytochrome c by some free radical agents. Science (1974) 0.75
Genetic engineering of human interferons from lymphoblastoid cells: III. Purification, physicochemical and biological properties of bacterial IFN-alpha J1. Adv Biotechnol Processes (1985) 0.75
Protection of cattle from infection with vaccinia virus by bovine interferon alpha C. Vet Rec (1989) 0.75
A simple plate test for screening colicine-inducing substances as a tool for the detection of potential carcinogens. Mutat Res (1978) 0.75
Genetic engineering of human interferons from lymphoblastoid cells: I. Cloning of interferon species expressed in Sendai-induced Namalva cells. Adv Biotechnol Processes (1985) 0.75
Cloning of a bovine interferon-alpha gene subfamily and comparisons between genetically engineered and leukocyte bovine interferons. Dev Biol Stand (1985) 0.75
Segregation patterns of an oversized P1 plasmid. Contrib Microbiol Immunol (1979) 0.75
Reactions of phenylalanine derivatives, methionine derivatives, and their mixtures in aqueous solution with pulse-radiolytically generated H atoms. Radiat Res (1974) 0.75
Cloning, expression and biological activity of a new variant of human interferon alpha identified in virus induced lymphoblastoid cells. Dev Biol Stand (1985) 0.75
DNA repair in the in vivo site specific excision of palindromic sequences. Prog Clin Biol Res (1985) 0.75